Angiogenesis Not Yet Recruiting Phase 3 Trials for Endostatin (DB06423)

IndicationStatusPhase
DBCOND0036757 (Angiogenesis)Not Yet Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02865304The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC PatientsTreatment